Z-LEED-FMK contains benzyloxycarbonyl protection, a LEED recognition motif, and a reactive FMK group. The compound is applied in studies of protease selectivity and irreversible enzyme modification. Researchers use it to dissect catalytic preferences and cleavage-site architecture. Its stable framework suits kinetic and mechanistic assays.
CAT No: HB00042
Z-LEED-FMK is a synthetic peptide-based fluoromethyl ketone inhibitor, specifically designed to target and irreversibly inhibit caspase family proteases. Structurally, it comprises a benzyloxycarbonyl (Z) group, a tetrapeptide sequence (Leu-Glu-Glu-Asp), and a fluoromethyl ketone (FMK) reactive moiety. As a cell-permeable, irreversible inhibitor, Z-LEED-FMK is widely recognized for its utility in dissecting apoptotic pathways and studying caspase-dependent cellular processes. Its selectivity for caspases, especially those recognizing the LEED motif, makes it a valuable tool for elucidating the molecular mechanisms underlying programmed cell death and related signaling cascades in various biological systems.
Apoptosis research: Z-LEED-FMK is extensively used in apoptosis studies to selectively block caspase activity, thereby enabling researchers to delineate caspase-dependent versus caspase-independent cell death mechanisms. By irreversibly binding to the active site cysteine of target caspases, this inhibitor effectively halts downstream proteolytic events, allowing for the assessment of the functional roles of specific caspases in cellular demise. Its application is particularly relevant in cell-based assays designed to map the sequence of molecular events during apoptosis.
Caspase substrate specificity analysis: The defined tetrapeptide sequence of Z-LEED-FMK serves as a substrate mimic, facilitating detailed investigations into the substrate recognition properties of caspases. Researchers utilize this compound to probe the sequence preferences and cleavage site selectivity of various caspase isoforms, thereby advancing our understanding of protease-substrate interactions. Such studies are crucial for characterizing caspase signaling networks and for the development of more selective protease inhibitors.
Cell signaling pathway elucidation: By selectively inhibiting caspase activity, Z-LEED-FMK provides a powerful means to dissect complex cell signaling pathways that intersect with apoptotic machinery. Its use helps clarify the interplay between caspase-mediated proteolysis and other signaling modules, such as those governing inflammation, cell cycle progression, or differentiation. This mechanistic insight is particularly valuable in experimental models where multiple protease families may be concurrently active.
Proteomic studies: In proteomic workflows, Z-LEED-FMK is employed to stabilize cellular protein profiles by preventing caspase-mediated cleavage during sample preparation. This application is essential for accurate identification and quantification of intact proteins and post-translational modifications, as it minimizes proteolytic artifacts that could confound downstream mass spectrometry or immunoblot analyses. The ability to preserve native protein architecture enhances the reliability of proteomic data derived from apoptotic or stressed cells.
Drug discovery and inhibitor screening: Z-LEED-FMK functions as a reference inhibitor in high-throughput screening platforms aimed at identifying novel caspase modulators. Its well-characterized mechanism of action and irreversible binding kinetics make it an ideal positive control for validating assay performance and benchmarking the potency of new small-molecule or peptide-based inhibitors. This role is central to the advancement of targeted therapeutics and the exploration of caspase biology in disease-relevant contexts.
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More